Skip to main content

Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results

The results support Vertex's hopes of developing a drug that can provide strong pain relief without the addictive potential of opioid medications.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.